openPR Logo
Press release

Oncology Information Systems Market worth $15.67 billion by 2030, growing at a CAGR of 8.50% - Exclusive Report by 360iResearch

03-13-2024 07:17 AM CET | Media & Telecommunications

Press release from: 360iResearch

Oncology Information Systems Market | 360iResearch

Oncology Information Systems Market | 360iResearch

The "Oncology Information Systems Market by Solutions (Advanced Visualization & Image Analysis Solutions, Brachytherapy Treatment Planning Systems, Chemotherapy Information System), Service (Consulting/Optimization Services, Implementation Services, Post-Sale & Maintenance Services), Application, End User - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.

The Global Oncology Information Systems Market to grow from USD 8.85 billion in 2023 to USD 15.67 billion by 2030, at a CAGR of 8.50%.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/oncology-information-systems?utm_source=openpr&utm_medium=referral&utm_campaign=sample

Oncology Information Systems (OIS) are integrated, specialized platforms designed to manage the complex data and workflow processes associated with cancer treatment. Oncology Information systems provide a comprehensive suite of tools that assist clinicians, oncologists, and healthcare providers in efficiently planning, managing, and monitoring the entire cancer care continuum from diagnosis to survivorship. The growing prevalence of cancer, focus on integrated healthcare systems, and rising demand for personalized medicine expansion of healthcare infrastructure increase market adoption. However, concerns regarding data security and privacy in storing and managing patient records may impede market growth. Nevertheless, enhanced cloud-based solutions for remote access and real-time collaboration among oncology specialists and the development of mobile applications for patient engagement and real-time monitoring are expected to create potential opportunities for market growth.

In the Americas, the demand for Oncology Information Systems (OIS) is driven by the increasing incidence of cancer, technological advancements, and the implementation of healthcare reforms supporting oncology research. Advanced healthcare infrastructure and high per capita healthcare expenditure contribute to a favorable market environment. In Canada, government initiatives and funding for cancer research support the adoption of OIS. European Union (EU) countries exhibit a high demand for OIS due to their well-established healthcare systems and active participation in cancer research. The General Data Protection Regulation (GDPR) has also influenced the development and implementation of OIS to ensure patient data security and privacy. Significant investments in personalized medicine and integrated care models are prevalent in the region. The OIS market in the Middle East and Africa is emerging, with the Middle East showing faster adoption due to increasing healthcare expenditure and infrastructure development. In Africa, the market growth is slower due to resource constraints; however, it presents a long-term opportunity with gradual economic and healthcare improvements. In the Asia-Pacific region, especially in China and Japan, government initiatives for cancer control, increasing healthcare expenditure, and the aging population are significant factors driving the OIS market. India, on the other hand, presents a rapidly growing market due to the rising incidence of cancer and ongoing improvements in healthcare infrastructure.

Market Segmentation & Coverage:

This research report categorizes the Oncology Information Systems Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Solutions, market is studied across Advanced Visualization & Image Analysis Solutions, Brachytherapy Treatment Planning Systems, Chemotherapy Information System, Clinical Decision Support Systems, Clinical Integration Solutions, Laboratory Information Systems, Oncology Electronic Medical Record (EHR), Patient Information Systems, Picture archiving & communication System (PACS) & VNA, Population Health Management, Radiation Dose Management Solutions, Radiology Information systems, Radiotherapy Treatment Planning Systems, Treatment Management Systems & Medical Image Analysis Systems, and Treatment Planning Systems. The Clinical Integration Solutions is projected to witness significant market share during forecast period.

Based on Service, market is studied across Consulting/Optimization Services, Implementation Services, and Post-Sale & Maintenance Services. The Implementation Services is projected to witness significant market share during forecast period.

Based on Application, market is studied across Medical Oncology, Radiation Oncology, and Surgical Oncology. The Radiation Oncology is projected to witness significant market share during forecast period.

Based on End User, market is studied across Ablation Care Centers & Cancer Care Centers, Government Institutions, Hospitals & Diagnostic Imaging Centers, and Research Facilities. The Government Institutions is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 39.07% in 2023, followed by Europe, Middle East & Africa.

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/oncology-information-systems?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Oncology Information Systems Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Oncology Information Systems Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Oncology Information Systems Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Advanced Data Systems, Advanced Data Systems Corporation, Allscripts Healthcare Solutions, Inc., Altai AS, CureMD.com, Inc., DOSIsoft SA, Elekta AB, EndoSoft LLC, Epic Systems Corporation, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc., International Business Machines Corporation, Karkinos Healthcare, Koninklijke Philips N.V., McKesson Corporation, MICA Information Systems, Inc., Oracle Corporation, RaySearch Laboratories, Siemens Healthineers AG, Sify Technologies, UnitedHealth Group Inc., and ViewRay Inc..

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Oncology Information Systems Market, by Solutions
7. Oncology Information Systems Market, by Service
8. Oncology Information Systems Market, by Application
9. Oncology Information Systems Market, by End User
10. Americas Oncology Information Systems Market
11. Asia-Pacific Oncology Information Systems Market
12. Europe, Middle East & Africa Oncology Information Systems Market
13. Competitive Landscape
14. Competitive Portfolio

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Oncology Information Systems Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Oncology Information Systems Market?
3. What is the competitive strategic window for opportunities in the Oncology Information Systems Market?
4. What are the technology trends and regulatory frameworks in the Oncology Information Systems Market?
5. What is the market share of the leading vendors in the Oncology Information Systems Market?
6. What modes and strategic moves are considered suitable for entering the Oncology Information Systems Market?

Read More @ https://www.360iresearch.com/library/intelligence/oncology-information-systems?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oncology Information Systems Market worth $15.67 billion by 2030, growing at a CAGR of 8.50% - Exclusive Report by 360iResearch here

News-ID: 3426536 • Views:

More Releases from 360iResearch

Hand Geometry Biometrics Market worth $216.26 million by 2030, growing at a CAGR of 11.79% - Exclusive Report by 360iResearch
Hand Geometry Biometrics Market worth $216.26 million by 2030, growing at a CAGR …
The "Hand Geometry Biometrics Market by Type (Biometric Software, Palm Scanner), End-user (BFSI, Building & Construction, Consumer Electronics), Application - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/hand-geometry-biometrics?utm_source=openpr&utm_medium=referral&utm_campaign=sample "Hand Geometry Biometrics Market Growth Fuelled by Security Demands and Technological Integrations" As global security concerns intensify, industries such as banking, healthcare, and government are increasingly adopting hand geometry biometrics for secure, tamper-resistant authentication. This surge
Satellite IoT Market worth $5.73 billion by 2030, growing at a CAGR of 20.30% - Exclusive Report by 360iResearch
Satellite IoT Market worth $5.73 billion by 2030, growing at a CAGR of 20.30% - …
The "Satellite IoT Market by Service Type (Direct to Satellite Services, Sat-IoT Backhaul Services), Frequency Band (Ka-band, Ku-band, L-band), End-Use - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. The Global Satellite IoT Market to grow from USD 1.57 billion in 2023 to USD 5.73 billion by 2030, at a CAGR of 20.30%. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/satellite-iot?utm_source=openpr&utm_medium=referral&utm_campaign=sample The utilization of satellite IoT is significantly growing across various regions,
Laboratory Chemicals Market worth $40.97 billion by 2030, growing at a CAGR of 8.99% - Exclusive Report by 360iResearch
Laboratory Chemicals Market worth $40.97 billion by 2030, growing at a CAGR of 8 …
The "Laboratory Chemicals Market by Type (Biochemistry, Carbohydrate Analysis, Cell/Tissue Culture), Application (Academia/Educational, Government, Healthcare & Pharmaceutical) - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. The Global Laboratory Chemicals Market to grow from USD 22.41 billion in 2023 to USD 40.97 billion by 2030, at a CAGR of 8.99%. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/laboratory-chemicals?utm_source=openpr&utm_medium=referral&utm_campaign=sample Laboratory chemicals include acids, solvents, reagents, and analytical standards for testing and experiments. Laboratory
Satellite IoT Market worth $5.73 billion by 2030, growing at a CAGR of 20.30% - Exclusive Report by 360iResearch
Satellite IoT Market worth $5.73 billion by 2030, growing at a CAGR of 20.30% - …
The "Satellite IoT Market by Service Type (Direct to Satellite Services, Sat-IoT Backhaul Services), Frequency Band (Ka-band, Ku-band, L-band), End-Use - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering. The Global Satellite IoT Market to grow from USD 1.57 billion in 2023 to USD 5.73 billion by 2030, at a CAGR of 20.30%. Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/satellite-iot?utm_source=openpr&utm_medium=referral&utm_campaign=sample The utilization of satellite IoT is significantly growing across various regions,

All 5 Releases


More Releases for Oncology

Immuno Oncology Assays Market Size, Immuno Oncology Assays Market Prediction, Im …
The Immuno Oncology Assays Market Report examines the Immuno Oncology Assays industry from a variety of angles, including market size, status, trends, and forecasts. It also gives a quick rundown of the top competitors and development opportunities in the market. The research contains a comprehensive study of the keyword market, split by companies, regions, types, and applications. The research goes into great detail on several aspects that have been studied as
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure. According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Allied Academies was founded by Jim and JoAnn Carland and
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Allied Academies was founded by Jim and JoAnn Carland and
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Allied Academies was founded by Jim and JoAnn Carland and
International Oncology Summit
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. International Oncology Summit will have an anticipated